0001723963-21-000005.txt : 20211124 0001723963-21-000005.hdr.sgml : 20211124 20211124122754 ACCESSION NUMBER: 0001723963-21-000005 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211124 DATE AS OF CHANGE: 20211124 EFFECTIVENESS DATE: 20211124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BreStem Therapeutics, Inc. CENTRAL INDEX KEY: 0001723963 IRS NUMBER: 821935111 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-405341 FILM NUMBER: 211443709 BUSINESS ADDRESS: STREET 1: 1001 WILLIAM MOORE DRIVE CITY: RALEIGH STATE: NC ZIP: 27606 BUSINESS PHONE: 919-513-6157 MAIL ADDRESS: STREET 1: 1001 WILLIAM MOORE DRIVE CITY: RALEIGH STATE: NC ZIP: 27606 D/A 1 primary_doc.xml X0708 D/A LIVE 0001723963 BreStem Therapeutics, Inc. 1001 WILLIAM MOORE DRIVE RALEIGH NC NORTH CAROLINA 27606 919-513-6157 NORTH CAROLINA None None Corporation true 2017 Ke Cheng c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Executive Officer Director Weili Zhou c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Director Weigang Wang c/o BreStem Therapeutics, Inc. 1001 William Moore Drive RALEIGH NC NORTH CAROLINA 27606 Director Other Health Care Decline to Disclose 06b true 0001723963-21-000004 2021-06-21 false true true false 0 3000000 3000000 0 false 3 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive any payments from the proceeds of this offering. false BreStem Therapeutics, Inc. /s/ Ke Cheng Ke Cheng Chief Executive Officer 2021-11-24